4//SEC Filing
Yamashita Elizabeth A. 4
Accession 0001209191-17-066692
CIK 0001649989other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:48 PM ET
Size
8.1 KB
Accession
0001209191-17-066692
Insider Transaction Report
Form 4
Yamashita Elizabeth A.
VP, Regulatory Affairs
Transactions
- Sale
Common Stock
2017-12-19$1.14/sh−6,151$7,012→ 80,818 total - Sale
Common Stock
2017-12-18$1.17/sh−1,509$1,766→ 86,969 total
Footnotes (4)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 - $1.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F3]Includes shares of common stock underlying RSUs reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on December 22, 2016. The vesting of RSUs was accelerated such that 100% of the shares underlying the RSU will vest on December 21, 2017.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 - $1.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
Documents
Issuer
Oncobiologics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001663252
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 7:48 PM ET
- Size
- 8.1 KB